Clinical predictors of early fluoxetine treatment response in obsessive–compulsive disorder
✍ Scribed by Eric A. Storch; Michael J. Larson; Nathan A. Shapira; Herbert E. Ward; Tanya K. Murphy; Gary R. Geffken; Holly Valerio; Wayne K. Goodman
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 113 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.20197
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The introduction of the SSRIs (selective serotonin reuptake inhibitors) over the past decade has provided exciting new opportunities for the treatment of obsessive-compulsive disorder (OCD). The serotonin hypothesis, based on the preferential response of OCD to the serotonin reuptake inhibitor, clom
## The current study examines the neuroendocrine response to intravenous clomipramine (IV CMI) in oral CMI-resistant obsessive-compulsive disorder (OCD) patients on day 1 and day 14 of treatment to identify predictors of response. Forty-four OCD patients with an inadequate response or poorly toleran